Table 4

 Clinical features at the time of diagnosis of hepatocellular carcinoma in 268 patients included in the study

Variablen% rate
HCV, hepatitis C virus; HBV, hepatitis B virus; PEI, percutaneous ethanol injection; TACE, transarterial chemoembolisation; RFA, radiofrequency ablation.
Sex
    Male/female204/6476.1–33.9%
Liver disease
    Chronic hepatitis94.1%
    Cirrhosis25995.9%
        Child-Pugh Class A20980.5%
        Child-Pugh Class B5019.4%
Aetiology
    HCV18769.7%
    HBV4717.5%
    HBV+HCV166.0%
    Alcohol145.2%
    Unknown62.2%
Ascites
    Absent/present236/3288.1–11.9%
Portal vein thrombosis
    Absent/present257/1195.9–4.1%
No of HCC nodules
    Single/multiple155/11357.8–42.2%
Diameter of (largest) HCC nodule
    <3 cm/>3 cm125/14345.9–54.1%
Treatment
    PEI13249.2%
    TACE10338.4%
    RFA145.2%
    Supportive197.2%